Evidence map›Paper›PMID 24860836›Full record

SynthesisJournal of immunology research2014

Rheumatic fever associated with antiphospholipid syndrome: systematic review.

Felipe da Silva, Jozélio de Carvalho

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in Journal of immunology research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pediatric APS: State of the Art.Current rheumatology reports · 2020
    Pooled it
  2. Article
  3. Infection-Triggered Antiphospholipid Syndrome: A Critical Overview.Open access rheumatology : research and reviews · 2025
    Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Felipe da SilvaEscola Bahiana de Medicina e Saúde Pública, 41810080 Salvador, BA, Brazil.
Jozélio de CarvalhoRheumatology Division, Centro Médico do Hospital Aliança, Rua das Violetas 42, AP. 502, 41810080 Salvador, BA, Brazil.
Escola Bahiana de Medicina e Saúde Pública · BRHospital São Rafael · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate the clinical associations between rheumatic fever and antiphospholipid syndrome and the impact of coexistence of these two diseases in an individual.

methodsSystematic review in electronics databases, regarding the period from 1983 to 2012. The keywords: "Rheumatic Fever," "Antiphospholipid Syndrome," and "Antiphospholipid Antibody Syndrome" are used.

resultswere identified 11 cases described in the literature about the association of rheumatic fever and antiphospholipid syndrome. Clinical presentation of rheumatic fever was characterized by the predominance of carditis (11/11) and chorea (7/11). Regarding the manifestations of APS, the stroke was observed in 7/11 (63.6%), with one of them having probable embolic origin.

conclusionThe present study brings the information that the association between APS and RF is quite rare, however, is of great clinical importance. Doctors who deal with the RF should include in their differential diagnosis the APS, especially in the presence of stroke in patients with RF and whose echocardiogram does not show intracavitary thrombi.

Indexed as

Antibodies, AntiphospholipidAntiphospholipid SyndromeChoreaDiagnosis, DifferentialHumansMyocarditisRheumatic FeverStrokeAntibodies, Antiphospholipid

Identifiers

PMID24860836
PMCPMC4016946
OpenAlexW2079457224

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.